Trade Summary

4 days ago, Kelly John Alexander, serving as CFO at Precision Biosciences Inc (DTIL), sold 8,149 shares at $3.84 per share, for a total transaction value of $31,292.00. Following this transaction, Kelly John Alexander now holds 125,883 shares of DTIL.

This sale represents a 6.00% decrease in Kelly John Alexander's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, February 18, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 19, 2026, 1 day after the trade was made.

Precision Biosciences Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.